Skip to main content
Biofrontera Inc. logo

Biofrontera Inc. — Investor Relations & Filings

Ticker · BFRI ISIN · US09077D1000 LEI · 984500444S8BE1EF0179 US Manufacturing
Filings indexed 350 across all filing types
Latest filing 2023-12-28 Regulatory Filings
Country US United States of America
Listing US BFRI

About Biofrontera Inc.

https://www.biofrontera-us.com/

Biofrontera Inc. is a biopharmaceutical company that commercializes a portfolio of pharmaceutical products for the treatment of dermatological conditions. The company specializes in photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used to treat actinic keratoses, a type of pre-cancerous skin lesion, and impetigo, a bacterial skin infection. Biofrontera focuses on establishing PDT as a standard of care in dermatology and utilizes a proprietary nanoemulsion technology to improve the stability and skin penetration of its formulations, potentially increasing clinical efficacy.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2023
Regulatory Filings
2023-12-28 English
Regulatory Filings 2023
Regulatory Filings
2023-12-27 English
Regulatory Filings 2023
Regulatory Filings
2023-12-15 English
Regulatory Filings 2023
Regulatory Filings
2023-11-29 English
Proxy Solicitation & Information Statement 2023
Proxy Solicitation & Information Statement
2023-11-17 English
Interim / Quarterly Report 2023
Interim / Quarterly Report Q3 2023
2023-11-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.